LC350189
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LC350189, covering 2013-06-11 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia [Phase 2]